Skip to main content
Top
Published in: Pediatric Nephrology 7/2006

01-07-2006 | Original Article

Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury

Authors: Howard Trachtman, Erica Christen, Avital Cnaan, Jilma Patrick, Volker Mai, Jaya Mishra, Aditya Jain, Nathan Bullington, Prasad Devarajan, Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial

Published in: Pediatric Nephrology | Issue 7/2006

Login to get access

Abstract

Background: Diarrhea-associated hemolytic uremic syndrome (D+HUS) causes acute renal failure. Neutrophil gelatinase-associated lipocalcin (NGAL) is an early indicator of kidney injury. Objective: To determine if urinary NGAL excretion is a biomarker of severe renal injury and predicts the need for dialysis in D+HUS. Methods: Patients were randomly selected from among participants in the SYNSORB Pk trial. Urine samples were collected daily if available during the first week of hospitalization. NGAL levels were determined by ELISA. Results: 34 children, age 5.9±3.9 yr, were studied; ten (29%) required dialysis. Patients were categorized based on urinary NGAL concentration within five days of hospitalization - <200 ng/ml and ≥200 ng/ml. Twenty patients (58%) had increased urinary NGAL excretion. The severity of D+HUS at enrollment was similar in the two groups. However, children with increased urinary NGAL levels had higher peak BUN and creatinine concentrations (P<0.01) and required dialysis more often, 9/20 versus 1/14 (P=0.024) compared to children with normal excretion. Conclusion: The majority of patients with D+HUS have renal tubular epithelial injury, as evidenced by elevated urinary NGAL excretion. Urinary NGAL levels below 200 ng/ml within five days of hospitalization may be an adjunctive marker that defines less severe renal involvement.
Appendix
Available only for authorised users
Literature
1.
go back to reference Trachtman H, Christen C (1999) Hemolytic uremic syndrome: current understanding of the pathogenesis and therapeutic trials and interventions. Curr Opin Pediatr 11:162–168CrossRef Trachtman H, Christen C (1999) Hemolytic uremic syndrome: current understanding of the pathogenesis and therapeutic trials and interventions. Curr Opin Pediatr 11:162–168CrossRef
2.
go back to reference Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073–1086PubMed Tarr PI, Gordon CA, Chandler WL (2005) Shiga-toxin-producing Escherichia coli and haemolytic uraemic syndrome. Lancet 365:1073–1086PubMed
3.
go back to reference Kaplan BA, Meyers KE, Schulman S (1998) The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 9:1126–1133PubMed Kaplan BA, Meyers KE, Schulman S (1998) The pathogenesis and treatment of hemolytic uremic syndrome. J Am Soc Nephrol 9:1126–1133PubMed
4.
go back to reference Andreoli SP, Trachtman H, Acheson DWK, Siegler RL, Obrig TG (2002) Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 17:293–298CrossRef Andreoli SP, Trachtman H, Acheson DWK, Siegler RL, Obrig TG (2002) Hemolytic uremic syndrome: epidemiology, pathophysiology, and therapy. Pediatr Nephrol 17:293–298CrossRef
5.
go back to reference Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DWK, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH (2003) Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: A randomized clinical trial. JAMA 290:1337–1344CrossRef Trachtman H, Cnaan A, Christen E, Gibbs K, Zhao S, Acheson DWK, Weiss R, Kaskel FJ, Spitzer A, Hirschman GH (2003) Effect of an oral Shiga toxin-binding agent on diarrhea-associated hemolytic uremic syndrome in children: A randomized clinical trial. JAMA 290:1337–1344CrossRef
6.
go back to reference Siegler RL (1994) Spectrum of extra-renal involvement in postdiarrheal hemolytic–uremic syndrome. J Pediatr 125:511–518CrossRef Siegler RL (1994) Spectrum of extra-renal involvement in postdiarrheal hemolytic–uremic syndrome. J Pediatr 125:511–518CrossRef
7.
go back to reference Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression. JAMA 290:1360–1370CrossRef Garg AX, Suri RS, Barrowman N, Rehman F, Matsell D, Rosas-Arellano MP, Salvadori M, Haynes RB, Clark WF (2003) Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: A systematic review, meta-analysis, and meta-regression. JAMA 290:1360–1370CrossRef
8.
go back to reference Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839CrossRef Ray PE, Liu XH (2001) Pathogenesis of Shiga toxin-induced hemolytic uremic syndrome. Pediatr Nephrol 16:823–839CrossRef
9.
go back to reference Kiyokawa N, Taguchi T, Mori T, Uchida H, Sato N, Takeda T, Fujimoto J (1998) Induction of apoptosis in normal renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J Infect Dis 178:178–184CrossRef Kiyokawa N, Taguchi T, Mori T, Uchida H, Sato N, Takeda T, Fujimoto J (1998) Induction of apoptosis in normal renal tubular epithelial cells by Escherichia coli Shiga toxins 1 and 2. J Infect Dis 178:178–184CrossRef
10.
go back to reference Hughes AK, Stricklett PK, Kohan DE (1998) Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int 54:426–437CrossRef Hughes AK, Stricklett PK, Kohan DE (1998) Cytotoxic effect of Shiga toxin-1 on human proximal tubule cells. Kidney Int 54:426–437CrossRef
11.
go back to reference Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035–1050CrossRef Noris M, Remuzzi G (2005) Hemolytic uremic syndrome. J Am Soc Nephrol 16:1035–1050CrossRef
12.
go back to reference Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalcin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534–2543CrossRef Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, Yang J, Barasch J, Devarajan P (2003) Identification of neutrophil gelatinase-associated lipocalcin as a novel early urinary biomarker for ischemic renal injury. J Am Soc Nephrol 14:2534–2543CrossRef
13.
go back to reference Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P (2004) Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalcin. J Am Soc Nephrol 15:3073–3082CrossRef Mishra J, Mori K, Ma Q, Kelly C, Yang J, Mitsnefes M, Barasch J, Devarajan P (2004) Amelioration of ischemic acute renal injury by neutrophil gelatinase-associated lipocalcin. J Am Soc Nephrol 15:3073–3082CrossRef
14.
go back to reference Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J (2005) Endocytic delivery of lipocalcin–siderophore–iron complex rescues the kidney ischemia–reperfusion injury. J Clin Invest 115:610–621CrossRef Mori K, Lee HT, Rapoport D, Drexler IR, Foster K, Yang J, Schmidt-Ott KM, Chen X, Li JY, Mishra J, Cheema FH, Markowitz G, Suganami T, Sawai K, Mukoyama M, Kunis C, D’Agati V, Devarajan P, Barasch J (2005) Endocytic delivery of lipocalcin–siderophore–iron complex rescues the kidney ischemia–reperfusion injury. J Clin Invest 115:610–621CrossRef
15.
go back to reference Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P (2005) Neutrophil gelatinase-associated lipocalcin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231–1238CrossRef Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, Kelly C, Ruff SM, Zahedi K, Shao M, Bean J, Mori K, Barasch J, Devarajan P (2005) Neutrophil gelatinase-associated lipocalcin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet 365:1231–1238CrossRef
16.
go back to reference Te Loo DM, Monnens LA, van den Heuvel LP, Gubler MC, Kockx MM (2001) Detection of apoptosis in kidney biopsies of patients with D+ hemolytic uremic syndrome. Pediatr Res 49:413–416CrossRef Te Loo DM, Monnens LA, van den Heuvel LP, Gubler MC, Kockx MM (2001) Detection of apoptosis in kidney biopsies of patients with D+ hemolytic uremic syndrome. Pediatr Res 49:413–416CrossRef
17.
go back to reference Nestoridi E, Kushak RI, Duguerre D, Grabowski EF, Ingelfinger JR (2005) Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int 67:2254–2266CrossRef Nestoridi E, Kushak RI, Duguerre D, Grabowski EF, Ingelfinger JR (2005) Up-regulation of tissue factor activity on human proximal tubular epithelial cells in response to Shiga toxin. Kidney Int 67:2254–2266CrossRef
18.
go back to reference Schulman SL, Kaplan BS (1996) Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not anuria. Pediatr Nephrol 10:671–674CrossRef Schulman SL, Kaplan BS (1996) Management of patients with hemolytic uremic syndrome demonstrating severe azotemia but not anuria. Pediatr Nephrol 10:671–674CrossRef
19.
go back to reference Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365:417–430CrossRef Lameire N, Van Biesen W, Vanholder R (2005) Acute renal failure. Lancet 365:417–430CrossRef
20.
go back to reference Ohlsson S, Wieslander J, Segelmark M (2003) Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin Exp Immunol 131:528–535CrossRef Ohlsson S, Wieslander J, Segelmark M (2003) Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin Exp Immunol 131:528–535CrossRef
Metadata
Title
Urinary neutrophil gelatinase-associated lipocalcin in D+HUS: a novel marker of renal injury
Authors
Howard Trachtman
Erica Christen
Avital Cnaan
Jilma Patrick
Volker Mai
Jaya Mishra
Aditya Jain
Nathan Bullington
Prasad Devarajan
Investigators of the HUS-SYNSORB Pk Multicenter Clinical Trial
Publication date
01-07-2006
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 7/2006
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-006-0146-y

Other articles of this Issue 7/2006

Pediatric Nephrology 7/2006 Go to the issue